Caplight Directory>Companies>Momentum Biotechnologies-preview>Momentum-bio


Momentum Biotechnologies

Momentum Biotechnologies

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://momentum.bio/

Company Overview

Momentum Biotechnologies is a biotechnology company that provides a single-cell functional proteomics platform for drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROmass spectrometry servicesdrug discovery servicesproteomics servicesproteomics CROhigh-throughput screeninghit-to-leadaffinity selection mass spectrometryASMSchemoproteomicssmall molecule discoverytargeted protein degradationhit characterizationmolecular glue discoverycovalent binding assaysRNA targetingcomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Momentum Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Momentum Biotechnologies Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Daniel Brooks

Chief Financial Officer

Executive Team

Momentum Biotechnologies Investors

Notable investors and investment history

InvestorRounds
Care EquityPrivate Equity
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2025

    Grew 21% QoQ from 19 to 23 employees.

  • Jun 8, 2025

    Grew 17% QoQ, from 18 to 21 employees.

View all signals

Momentum Biotechnologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Momentum Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Momentum Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range22
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.